Monitoring of Inflammatory Bowel Disease in Pregnancy: A Review of the Different Modalities

Reem Al-Jabri; Panu Wetwittayakhlang; Peter L Lakatos

doi:10.3390/jcm12237343

Monitoring of Inflammatory Bowel Disease in Pregnancy: A Review of the Different Modalities

J Clin Med. 2023 Nov 27;12(23):7343. doi: 10.3390/jcm12237343.

Authors

Reem Al-Jabri¹, Panu Wetwittayakhlang², Peter L Lakatos^{1

3}

Affiliations

¹ Division of Gastroenterology and Hepatology, McGill University Health Center, Montreal, QC H3G 1Y6, Canada.
² Gastroenterology and Hepatology Unit, Division of Internal Medicine, Faculty of Medicine, Prince of Songkla University, Songkhla 90110, Thailand.
³ Department of Oncology and Medicine, Semmelweis University, 1085 Budapest, Hungary.

Abstract

Inflammatory Bowel Disease (IBD) significantly affects women in their reproductive years. Understanding the relationship between IBD and pregnancy is crucial, given its impact across pre-gestational, gestational, and postpartum phases. Monitoring IBD activity during pregnancy involves various modalities. This review discusses these modalities, focusing on the efficacy and safety of Small Intestine Ultrasound (IUS) as a noninvasive and reliable option. While IUS has gained popularity, its technique-sensitive nature necessitates trained staff for optimal usage.

Keywords: CRP; CT; MRI; colonoscopy; fecal calprotectin; inflammatory bowel disease; pregnancy; sigmoidoscopy; small intestinal ultrasound.

Publication types

Review

Grants and funding

This research received no external funding.